Gene therapy of Retinal Diseases


Gene therapy is growing potentially in the field of ophthalmology having mailnly three characteristics- convenience in terms of injections and eye surgery, tight blood-ocular barriers which save other organ from contamination, its immune-privileged status facilitating the accommodation to the antigenicity of a viral vector.


  • Adeno-associated Viral Gene Therapy
  • Laser Congenital Amaurosis
  • Usher’s Syndrome

Related Conference of Gene therapy of Retinal Diseases

December 15-16, 2022

3rd World Congress on Ophthalmology & Optometry

London, UK
February 02-03, 2023

6th International Eye and Vision Congress

Barcelona, Spain
February 20-21, 2023

4th International Conference on Ear Nose & Throat

Singapore City, Singapore
April 20-21, 2023

8th International Conference on Eye and Vision

Paris, France
May 17-18, 2023

23rd Global Ophthalmologists Annual Meeting

Prague, Czech Republic
May 24-25, 2023

3rd International Conference on Optics & Photonics

Montreal, Canada
May 31-01, 2023

9th Global Ophthalmology Meeting

Rome, Italy
July 26-27, 2023

17th International Conference on Hepatology

Singapore City, Singapore
July 31-01, 2023

37th European Ophthalmology Congress

Vancouver, Canada
August 28-29, 2023

22nd Asia Pacific Ophthalmologists Annual Meeting

Tokyo, Japan
September 18-19, 2023

33rd International Congress on Vision Science and Eye

Rome, Italy
October 09-10, 2023

4th International Conference on Optometry

Prague, Czech Republic
November 01-02, 2023

19th International Conference on Metabolomics

Rome, Italy

Gene therapy of Retinal Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in